Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture

被引：52

作者：

Bafna, Khushboo ^{[1
,2
]}

White, Kris ^{[3
,4
]}

Harish, Balasubramanian ^{[2
,5
]}

Rosales, Romel ^{[3
,4
]}

Ramelot, Theresa A. ^{[1
,2
]}

Acton, Thomas B. ^{[1
,2
]}

Moreno, Elena ^{[3
,4
]}

Kehrer, Thomas ^{[3
,4
]}

Miorin, Lisa ^{[3
,4
]}

Royer, Catherine A. ^{[2
,5
]}

Garcia-Sastre, Adolfo ^{[3
,4
,6
,7
]}

Krug, Robert M. ^{[8
]}

Montelione, Gaetano T. ^{[1
,2
]}

机构：

[1] Rensselaer Polytech Inst, Dept Chem & Chem Biol, Troy, NY 12180 USA

[2] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Sci, Troy, NY 12180 USA

[3] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA

[4] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA

[5] Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA

[6] Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA

[7] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA

[8] Univ Texas Austin, John Ring LaMontagne Ctr Infect Dis, Inst Cellular & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA

来源：

CELL REPORTS | 2021年 / 35卷 / 07期

基金：

美国国家卫生研究院;

关键词：

SARS-CORONAVIRUS; DOCKING; ISG15; COMBINATION; SEQUENCE; BINDING;

D O I：

10.1016/j.celrep.2021.109133

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Effective control of COVID-19 requires antivirals directed against SARS-CoV-2. We assessed 10 hepatitis C virus (HCV) protease-inhibitor drugs as potential SARS-CoV-2 antivirals. There is a striking structural similarity of the substrate binding clefts of SARS-CoV-2 main protease (M-pro) and HCV NS3/4A protease. Virtual docking experiments show that these HCV drugs can potentially bind into the M-pro substrate-binding cleft. We show that seven HCV drugs inhibit both SARS-CoV-2 M-pro protease activity and SARS-CoV-2 virus replication in Vero and/or human cells. However, their M-pro inhibiting activities did not correlate with their antiviral activities. This conundrum is resolved by demonstrating that four HCV protease inhibitor drugs, simeprevir, vaniprevir, paritaprevir, and grazoprevir inhibit the SARS CoV-2 papain-like protease (PLpro). HCV drugs that inhibit PLpro synergize with the viral polymerase inhibitor remdesivir to inhibit virus replication, increasing remdesivir's antiviral activity as much as 10-fold, while those that only inhibit M-pro do not synergize with remdesivir.

引用

页数：20

共 54 条

[31] The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease [J].

McGonagle, Dennis ;

Sharif, Kassem ;

O'Regan, Anthony ;

Bridgewood, Charlie .

AUTOIMMUNITY REVIEWS, 2020, 19 (06)

[32] AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility [J].

Morris, Garrett M. ;

Huey, Ruth ;

Lindstrom, William ;

Sanner, Michel F. ;

Belew, Richard K. ;

Goodsell, David S. ;

Olson, Arthur J. .

JOURNAL OF COMPUTATIONAL CHEMISTRY, 2009, 30 (16) :2785-2791

[33]

Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO

[34]

2-B

[35] Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors [J].

Osipiuk, Jerzy ;

Azizi, Saara-Anne ;

Dvorkin, Steve ;

Endres, Michael ;

Jedrzejczak, Robert ;

Jones, Krysten A. ;

Kang, Soowon ;

Kathayat, Rahul S. ;

Kim, Youngchang ;

Lisnyak, Vladislav G. ;

Maki, Samantha L. ;

Nicolaescu, Vlad ;

Taylor, Cooper A. ;

Tesar, Christine ;

Zhang, Yu-An ;

Zhou, Zhiyao ;

Randall, Glenn ;

Michalska, Karolina ;

Snyder, Scott A. ;

Dickinson, Bryan C. ;

Joachimiak, Andrzej .

NATURE COMMUNICATIONS, 2021, 12 (01)

[36] Expression and Cleavage of Middle East Respiratory Syndrome Coronavirus nsp3-4 Polyprotein Induce the Formation of Double-Membrane Vesicles That Mimic Those Associated with Coronaviral RNA Replication [J].

Oudshoorn, Diede ;

Rijs, Kevin ;

Limpens, Ronald W. A. L. ;

Groen, Kevin ;

Koster, Abraham J. ;

Snijder, Eric J. ;

Kikkert, Marjolein ;

Barcena, Montserrat .

MBIO, 2017, 8 (06)

[37] Resistance outside the substrate envelope: hepatitis C NS3/4A protease inhibitors [J].

Ozen, Aysegul ;

Prachanronarong, Kristina ;

Matthew, Ashley N. ;

Soumana, Djade I. ;

Schiffer, Celia A. .

CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2019, 54 (01) :11-26

[38] Discovery of the HCVNS3/4A protease inhibitor (1R,5S)-N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (Sch 503034) II.: Key steps in structure-based optimization [J].

Prongay, Andrew J. ;

Guo, Zhuyan ;

Yao, Nanhua ;

Pichardo, John ;

Fischmann, Thierry ;

Strickland, Corey ;

Myers, Joseph, Jr. ;

Weber, Patricia C. ;

Beyer, Brian M. ;

Ingram, Richard ;

Hong, Zhi ;

Prosise, Winifred W. ;

Ramanathan, Lata ;

Taremi, S. Shane ;

Yarosh-Tomaine, Taisa ;

Zhang, Rumin ;

Senior, Mary ;

Yang, Rong-Sheng ;

Malcolm, Bruce ;

Arasappan, Ashok ;

Bennett, Frank ;

Bogen, Stephane L. ;

Chen, Kevin ;

Jao, Edwin ;

Liu, Yi-Tsung ;

Lovey, Raymond G. ;

Saksena, Anil K. ;

Venkatraman, Srikanth ;

Girijavallabhan, Viyyoor ;

Njoroge, F. George ;

Madison, Vincent .

JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (10) :2310-2318

[39]

Qi J., 2020, STRUCTURAL BIOCHEMIC

[40] A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication [J].

Ratia, Kiira ;

Pegan, Scott ;

Takayama, Jun ;

Sleeman, Katrina ;

Coughlin, Melissa ;

Baliji, Surendranath ;

Chaudhuri, Rima ;

Fu, Wentao ;

Prabhakar, Bellur S. ;

Johnson, Michael E. ;

Baker, Susan C. ;

Ghosh, Arun K. ;

Mesecar, Andrew D. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (42) :16119-16124

← 1 2 3 4 5 6 →